Positron Emission Tomography in Prostate Cancer
Completed · Not applicable
Conditions studied: Prostate Cancer
In brief
RATIONALE: Diagnostic procedures, such as positron emission tomography using carbon-11 acetate, may help find metastases from prostate cancer and may help predict whether prostate cancer will come back after treatment. PURPOSE: This clinical trial is studying how well positron emission tomography using carbon-11 acetate works in finding metastases and predicting recurrence in patients with prostate cancer who are at risk for recurrence after treatment.
Key facts
- Study ID
- NCT00121212
- Run by
- Washington University School of Medicine
- People needed
- 179
- Starts
- 2003-07-01
- Expected to finish
- 2015-10-01
- Last updated by the study team
- 2015-10-30
Who can join
Age: any. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Newly diagnosed prostate cancer
- Has completed conventional staging examinations, including biopsy with Gleason score, CT scan of the abdomen and pelvis, and whole-body bone scintigraphy AND conventional staging examinations negative
- Candidate for curative radical prostatectomy OR curative radiotherapy OR staging lymphadenectomy prior to surgery
- Deemed to be at medium or high risk for recurrence after initial curative treatment, as defined by 1 of the following criteria:
- Gleason score 7 AND prostate-specific antigen (PSA) 10-20 ng/mL
- Gleason score ≥ 8 AND PSA < 10 ng/mL
- Gleason score ≥ 8 AND PSA > 10 ng/mL
- Any Gleason score AND PSA > 20 ng/mL
- Exclusion Therapy:
- Not a candidate for treatment by surgery or radiation therapy with curative intent
- Inability to give informed consent
- Patients with other invasive malignancies, with the exception of non-melanoma skin cancer, who had (or have) any evidence of other cancer present within the last 5 years
Where it is running
- Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis — St Louis, Missouri, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.